Počet záznamov: 1
sunitinib
SYS d000077210 LBL 00000nx^^^2200181-^^45^^ 005 20240119195325.9 100 $a 20190101asloy0103 ba0 152 $b mesh 250 $a sunitinib $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $8 slo 300 1-
$a 2019 (2003) $8 eng 330 1-
$a An indole and pyrrole derivative that inhibits VEGFR-2 and PDGFR BETA RECEPTOR TYROSINE KINASES. It is used as an antineoplastic agent for the treatment of GASTROINTESTINAL STROMAL TUMORS, and for treatment of advanced or metastatic RENAL CELL CARCINOMA. $8 eng 450 $a sunitinib malát $5 e $8 slo 450 $a Sutent $5 e $8 slo 686 $a D03.383.129.578.823 686 $a D03.633.100.473.877 750 $a Sunitinib $8 eng 801 -0
$a SK $b BA006 $c 20190310 801 -2
$a SK $b BA006 $c 20190710 980 $x M
Počet záznamov: 1